Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
|
ES |
|
N
|
NVR Inc
F:NVE
|
US |
|
Hydrogenpro ASA
OTC:HYPRF
|
NO |
|
C
|
Creative Technology Ltd
XMUN:CTL
|
SG |
|
H
|
Honda Motor Co Ltd
SWB:HDMA
|
JP |
|
W
|
Western Alliance Bancorp
XBER:WEA
|
US |
|
iRobot Corp
NASDAQ:IRBT
|
US |
|
4
|
4Basebio PLC
LSE:4BB
|
UK |
|
Palatin Technologies Inc
F:PTN
|
US |
|
Camden Property Trust
NYSE:CPT
|
US |
|
D
|
Deutsche Bank AG
XBER:DBK
|
DE |
|
Danone SA
PAR:BN
|
FR |
|
King Copper Discovery Corp
F:3RI0
|
CA |
|
Pexip Holding ASA
OSE:PEXIP
|
NO |
|
Interpublic Group of Companies Inc
NYSE:IPG
|
US |
|
G
|
Global Power Synergy PCL
SET:GPSC
|
TH |
|
P
|
Popular Inc
SWB:PP4A
|
PR |
Wall St Price Targets
ROVI Price Targets Summary
Laboratorios Farmaceuticos ROVI SA
According to Wall Street analysts, the average 1-year price target for ROVI is 81.53 EUR with a low forecast of 64.84 EUR and a high forecast of 105 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ROVI's stock price target?
Price Target
81.53
EUR
According to Wall Street analysts, the average 1-year price target for ROVI is 81.53 EUR with a low forecast of 64.84 EUR and a high forecast of 105 EUR.
What is the Revenue forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 5 years is 15%.
